Allianz Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Allianz Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,665	Closed	-$1.54M	–	2297
2022 Q1	$1.54M	Hold	21,665	–	–	﹤0.01%	1698
2021 Q4	$1.62M	Buy	+21,665	New	+$1.7M	﹤0.01%	1698
2019 Q1	–	Sell	-13,215	Closed	-$936K	–	2694
2018 Q4	$936K	Buy	13,215 +463	+4%	+$35.5K	﹤0.01%	2060
2018 Q3	$1.09M	Buy	12,752 +10,194	+399%	+$1.02M	﹤0.01%	2194
2018 Q2	$296K	Buy	+2,558	New	+$255K	﹤0.01%	2485
2014 Q4	–	Sell	-6,030	Closed	-$239K	–	2360
2014 Q3	$239K	Sell	6,030 -40,585	-87%	-$1.62M	﹤0.01%	2113
2014 Q2	$2.01M	Sell	46,615 -4,150	-8%	-$158K	﹤0.01%	1207
2014 Q1	$2.03M	Buy	+50,765	New	+$1.84M	﹤0.01%	1202

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management's ENTA Position: Q2 2022 in Review

Allianz Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2022, closing a stake of 21,665 shares — an estimated $1.54M sold.

Allianz Asset Management first reported a position in ENTA in Q1 2014 and held it in 8 quarters. The position peaked at $2.03M in Q1 2014. 154 funds tracked by Wall St. Rank hold ENTA as of Q2 2022.

Allianz Asset Management reported no remaining Enanta Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Allianz Asset Management sold 21,665 Enanta Pharmaceuticals shares in Q2 2022, an estimated $1.54M.
Allianz Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2014 and held it in 8 quarters.
Allianz Asset Management's Enanta Pharmaceuticals position peaked at $2.03M in Q1 2014.
154 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2022.

Based on Allianz Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.